Cytori Therapeutics To Present at the 25th Annual Roth Conference on March 18

  Cytori Therapeutics To Present at the 25th Annual Roth Conference on March
  18

25th Annual ROTH Conference

Business Wire

SAN DIEGO -- March 11, 2013

Cytori Therapeutics Inc. (NASDAQ: CYTX) will present and provide a corporate
update from the 25^th Annual Roth Conference on Monday, March 18 at 4:30 PM
PT.

The presentation will be webcast and may be accessed under “Webcasts” under
Cytori’s Investor Relations section of the website. The webcast can be viewed
live and will be available for replay after the presentation on the Company's
website.

About Cytori

Cytori Therapeutics, Inc. is developing cell therapies based on autologous
adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and
repair soft tissue defects. Our scientific data suggest ADRCs improve blood
flow, moderate the inflammatory response and keep tissue at risk of dying
alive. As a result, we believe these cells can be applied across multiple
“ischemic” conditions. These therapies are made available to the physician and
patient at the point-of-care by Cytori’s proprietary technologies and
products, including the Celution® system product family. www.cytori.com

Contact:

Cytori Therapeutics Inc.
Megan McCormick, +1-858-875-5279
mmccormick@cytori.com
 
Press spacebar to pause and continue. Press esc to stop.